Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Updated PBS-listing for Trifluridine / Tipiracil in treatment of pre-treated metastatic gastric cancer including gastroesophageal junction cancer

Drugline Volume 397

Trifluridine/tipiracil is now available on the Pharmaceutical Benefits Scheme (PBS) for pre-treated cancer of the stomach or gastro-oesophageal junction. In the TAGS trial, trifluridine/tipiracil was demonstrated to significantly prolong overall survival in pre-treated gastric…

Read more

Combination Inhaler for Mild Asthma

Drugline Volume 396

The Pharmaceutical Benefits Scheme (PBS) has recently expanded the listing criteria for Symbicort®. Symbicort® contains the corticosteroid, budesonide plus the long-acting β2-agonist (LABA), formoterol. The new PBS listing allows Symbicort® to be used as reliever therapy in the management of…

Read more

Insulin Glargine on the PBS

Drugline Volume 395

From 1st July 2020, Lantus® products will no longer be available on the Pharmaceutical Benefits Scheme (PBS). Lantus® contains insulin glargine, a long-acting insulin analogue that is indicated for the management of type 1…

Read more

PBS Changes for Common Antibiotics

Drugline Volume 394

The Pharmaceutical Benefits Scheme (PBS) has recently made changes to the listings of some commonly prescribed antibiotics. These updates are in response to a Department of Health review in which one in five repeat…

Read more

Neuraminidase Inhibitors for Influenza

Drugline Volume 393

Neuraminidase inhibitors are a class of medications used in the management of influenza A and B infection. Neuraminidase is an enzyme found on the surface of the influenza virus that is important for the…

Read more

National COVID-19 Guidelines

Drugline Volume 392

The coronavirus disease (COVID-19) pandemic is presenting a range of challenges to healthcare professionals. One of the biggest issues in any rapidly evolving space is the ability to access current and reliable information. A…

Read more
Load More